Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-25T20:21:37.220Z Has data issue: false hasContentIssue false

Active placebos in antidepressant trials

Published online by Cambridge University Press:  03 January 2018

J. M. Cooney*
Affiliation:
14 The Mead, Beckenham, Kent BF3 5PE
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Copyright
Copyright © 1998 The Royal College of Psychiatrists 

References

Charles, H. C. Lazeyras, F. Kiishnan, K. R. R. et al (1995) Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using localised spectroscopy. Progress in Psychopharmacology and Biological Psychiatry, 18, 11211127.Google Scholar
Cooney, J. M. O'Keane, V. Lucey, J. V. et al (1997) The specificity of the pyridostigmine/growth hormone challenge in the diagnosis of depression. Biological Psychiatry, 42, 827833.Google Scholar
Gillin, J. C. Laurellio, J. Kelsoe, J. R. et al (1995) No antidepressant effect of biperidan compared with placebo in depression: a double-blind 6-week clinical trial. Psychiatric Research, 58, 99105.CrossRefGoogle ScholarPubMed
Janowsky, D. S. & Overstreet, D. H. (1995) The role of acetylcholine in mood disorders. In Psychopharmacology: The Fourth Generation of Progress (eds F. E. Bloom & D. J. Kupfer), pp. 945956. New York: Raven Press.Google Scholar
Moncrieff, J. Wessely, S. & Hardy, R. (1998) Meta-analysis of trials comparing antidepressants with active placebos. British Journal of Psychiatry, 172, 227231.Google Scholar
Renshaw, P. F. Lafer, B. Babb, S. M. et al (1997) Brain choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biological Psychiatry, 41, 837843.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.